One-Pot Friedländer
Quinoline Synthesis: Scope and Limitations

An-Hu Li; David J. Beard; Heather Coate; Ayako Honda; Mridula Kadalbajoo; Andrew Kleinberg; Radoslaw Laufer; Kristen M. Mulvihill; Anthony Nigro; Pawan Rastogi; Dan Sherman; Kam W. Siu; Arno G. Steinig; Ti Wang; Doug Werner; Andrew P. Crew; Mark J. Mulvihill

doi:10.1055/s-0029-1218701

PAPER

One-Pot Friedländer Quinoline Synthesis: Scope and Limitations

An-Hu Li*, David J. Beard, Heather Coate, Ayako Honda, Mridula Kadalbajoo, Andrew Kleinberg, Radoslaw Laufer, Kristen M. Mulvihill, Anthony Nigro, Pawan Rastogi, Dan Sherman, Kam W. Siu, Arno G. Steinig, Ti Wang, Doug Werner, Andrew P. Crew, Mark J. Mulvihill
Department of Cancer Chemistry, OSI Pharmaceuticals, Inc., 1 Bioscience Park Drive, Farmingdale, NY 11735, USA
Fax: +1(631)8455671; e-Mail: ali@osip.com;

Abstract

Alle Artikel dieser Rubrik

Abstract

A highly effective one-pot Friedländer quinoline synthesis from o-nitroarylcarbaldehydes and ketones or aldehydes was developed and the scope and limitations of the method were examined. The o-nitroarylcarbaldehydes were reduced to o-aminoarylcarbaldehydes with iron in the presence of a catalytic amount of aqueous hydrochloric acid; the amino compounds were then condensed in situ with ketones or aldehydes to form mono- or disubstituted quinolines, respectively, in good-to-excellent yields (58-100%).

Key words

quinolines - condensation - heterocycles - aldehydes - ketones

Volltext

Referenzen

References

For recent reviews, see:

1a Stocks PA. Raynes KJ. Ward SA. In Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery (Infectious Disease) Rosenthal PJ. Humana; Totawa / NJ: 2001. Chap. 13. p.235

1b Waters NC. Dow GS. Kozar MP. Expert Opin. Ther. Pat. 2004, 14: 1125

1c Fitch CD. Life Sci. 2004, 74: 1957

1d Olliaro PL. Taylor WRJ. J. Exp. Biol. 2003, 206: 3753

1e Michael JP. Nat. Prod. Rep. 2004, 21: 650

2a Tsou H.-R. Overbeek-Klumpers EG. Hallett WA. Reich MF. Floyd MB. Johnson BD. Michalak RS. Nilakantan R. Discafani C. Golas J. Rabindran SK. Shen R. Shi X. Wang Y.-F. Upeslacis J. Wissner A. J. Med. Chem. 2005, 48: 1107

For a review, see:

2b Boschelli DH. Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2002, 2: 1051

2c Kubo K. Ohyama S.-i. Shimizu T. Takami A. Murooka H. Nishitoba T. Kato S. Yagi M. Kobayashi Y. Iinuma N. Isoe T. Nakamura K. Iijima H. Osawa T. Izawa T. Bioorg. Med. Chem. 2003, 11: 5117

2d Golas JM. Arndt K. Etienne C. Lucas J. Nardin D. Gibbons J. Frost P. Ye F. Boschelli DH. Boschelli F. Cancer Res. 2003, 63: 375

2e Wu J. Li W. Craddock BP. Foreman KW. Mulvihill MJ. Ji Q.-s. Miller WT. Hubbard SR. EMBO J. 2008, 27: 1985

2f Mulvihill MJ. Ji Q.-S. Coate HR. Cooke A. Dong H. Feng L. Foreman K. Rosenfeld-Franklin M. Honda A. Mak G. Mulvihill KM. Nigro AI. O’Connor M. Pirrit C. Steinig AG. Siu K. Stolz KM. Sun Y. Tavares PAR. Yao Y. Gibson NW. Bioorg. Med. Chem. 2008, 16: 1359

2g Ji Q.-s. Mulvihill MJ. Rosenfeld-Franklin M. Cooke A. Feng L. Mak G. O’Connor M. Yao Y. Pirritt C. Buck E. Eyzaguirre A. Arnold LD. Gibson NW. Pachter JA. Mol. Cancer Ther. 2007, 6: 2158

2h Mulvihill MJ. Cooke A. Rosenfeld-Franklin M. Buck E. Foreman K. Landfair D. O’Connor M. Pirritt C. Sun Y. Yao Y. Arnold LD. Gibson NW. Ji Q.-s. Future Med. Chem. 2009, 1: 1153

3a For a review, see: Cheng C.-C. Yan S.-J. Org. React. (N. Y.) 1982, 28: 37

For a recent paper on the mechanism, see:

3b Muchowski JM. Maddox ML. Can. J. Chem. 2004, 82: 461

4a McNaughton BR. Miller BL. Org. Lett. 2003, 5: 4257

4b Eckert H. Angew. Chem. 1981, 93: 216

4c Motokura K. Mizugaki T. Ebitani K. Kaneda K. Tetrahedron Lett. 2004, 45: 6029

4d Cho CS. Kim BT. Choi H.-J. Kim T.-J. Shim SC. Tetrahedron 2003, 59: 7997

4e Martinez R. Ramon DJ. Yus M. Eur. J. Org. Chem. 2007, 1599

4f Cho CS. Ren WX. Shim SC. Tetrahedron Lett. 2006, 47: 6781

4g Cho CS. Ren WX. Shim SC. Bull. Korean Chem. Soc. 2005, 26: 1286

5 Li A.-H. Ahmed E. Chen X. Cox M. Crew AP. Dong H.-Q. Jin M. Ma L. Panicker B. Siu KW. Steinig AG. Stolz KM. Tavares PAR. Volk B. Weng Q. Werner D. Mulvihill MJ. Org. Biomol. Chem. 2007, 5: 61

6 Arnold LD, Cesario C, Coate H, Crew AP, Dong H, Foreman K, Honda A, Laufer R, Li A.-H, Mulvihill KM, Mulvihill MJ, Nigro A, Panicker B, Steinig AG, Sun Y, Weng Q, Werner DS, Wyle MJ, and Zhang T. inventors; WO 2005097800 . , ; Chem. Abstr. 2005, 142, 405928

7 The Hammett substituent constant (σ value) for the para-Me₂N group is -0.205, suggesting that it has an electron-donating effect. See: Hammett LP. J. Am. Chem. Soc. 1937, 59: 96

8 Longer condensation times have also been reported for the reaction of the intermediate 1-aminonaphthalene-2-carboxaldehyde with 1,3-diacetylbenzene (31 h) and 2,6-diacetylpyridine (17 h) under essentially the same reaction conditions (KOH in refluxing EtOH); see: Riesgo EC. Jin X. Thummel RP. J. Org. Chem. 1996, 61 : 3017

9a Fournet A. Vagneur B. Richomme P. Bruneton J. Can. J. Chem. 1989, 67: 2116

9b Fournet A. Hocquemiller R. Roblot F. Cavé A. Richomme P. Bruneton J. J. Nat. Prod. 1993, 56: 1547

10 Caron S. Desfossés S. Dionne R. Théberge N. Burnell RH. J. Nat. Prod. 1993, 56: 138

11 The same results were obtained in the 1,8-naphthyridine system when NaOH was used as the base. See: Dormer PG. Eng KK. Farr RN. Humphrey GR. McWilliams GC. Reider PJ. Sager JW. Volante RP. J. Org. Chem. 2003, 68: 467